Serum cystatin C level is associated with locomotive syndrome risk and can be an early predictor in community-living people: The Yakumo study

References

• Nakamura K. A “society and the; locomotive syndrome”. J Orthop Sci. 2008;13:1–2.
   PubMed Web of Science ®Google Scholar
• Nakamura K. The concept and treatment of locomotive syndrome: its acceptance and spread in Japan. J Orthop Sci. 2011;16:489–91.
   PubMed Web of Science ®Google Scholar
• Japanese orthopaedic Association. Locomotive syndrome. In: Locomotive Challenge! Council, editors. Locomotive syndrome pamphlet 2015. Tokyo: Japanese Orthopaedic Association; 2015.
   Google Scholar
• Yoshimura Y, Muraki S, Oka H, Tanaka S, Ogata T, Kawaguchi H, et al. Association between new indices in the locomotive syndrome risk test and decline in mobility: third survey of the ROAD study. J Orthop Sci. 2015;20:896–905.
   PubMed Web of Science ®Google Scholar
• Imagama S, Hasegawa Y, Ando K, Kobayashi K, Hida T, Ito K, et al. Staged decrease of physical ability on the locomotive syndrome risk test is related to neuropathic pain, nociceptive pain, shoulder complains, and quality of life in middle-aged and elderly people–The utility of the locomotive syndrome risk test. Mod Rheumatol. 2017;27:1051–6.
   PubMed Web of Science ®Google Scholar
• Servais A, Giral P, Bernard M, Brucketrt E, Deray G, Isnard Bagnis C. Is serum cystatin-C a reliable marker for metabolic syndrome?. Am J Med. 2008;121:426–32.
   PubMed Web of Science ®Google Scholar
• Battistoni A, Rubattu S, Volpe M. Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases. Int J Cardiol. 2012;157:160–8.
   PubMed Web of Science ®Google Scholar
• Imagama S, Hasegawa Y, Wakao N, Hirano K, Hamajima N, Ishiguro N. Influence of lumbar kyphosis and back muscle strength on the symptoms of gastroesophageal reflux disease in middle-aged and elderly people. Eur Spine J. 2012;21:2149–57.
   PubMed Web of Science ®Google Scholar
• Imagama S, Hasegawa Y, Matsuyama Y, Sakai Y, Ito Z, Hamajima N, Ishiguro N. Influence of sagittal balance and physical ability associated with exercise on quality of life in middle-aged and elderly people. Arch Osteoporos. 2011;6:13–20.
   PubMedGoogle Scholar
• Imagama S, Hasegawa Y, Seki T, Matsuyama Y, Sakai Y, Ito Z, et al. The effect of β-carotene on lumbar osteophyte formation. Spine. 2011;36:2293–8.
   PubMed Web of Science ®Google Scholar
• Imagama S, Matsuyama Y, Hasegawa Y, Sakai Y, Ito Z, Ishiguro N, Hamajima N. Back muscle strength and spinal mobility are predictors of quality of life in middle-aged and elderly males. Eur Spine J. 2011;20:954–61.
   PubMed Web of Science ®Google Scholar
• Seichi A, Hoshino Y, Doi T, Akai M, Tobimatsu Y, Iwaya T. Development of a screening tool for risk of locomotive syndrome in the elderly: the 25-question geriatric locomotive function. J Orthop Sci. 2012;17:163–72.
   PubMed Web of Science ®Google Scholar
• Muramoto A, Imagama S, Ito Z, Tauchi R, Ishiguro N, Hasegawa Y. Threshold values of physical performance tests for locomotive syndrome. J Orthop Sci. 2013;18:618–26.
   PubMed Web of Science ®Google Scholar
• Podsiadlo D, Richardson S. The timed ‘Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142–8.
   PubMed Web of Science ®Google Scholar
• Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32–5.
   PubMed Web of Science ®Google Scholar
• Hirano K, Imagama S, Hasegawa Y, Wakao N, Muramoto A, Ishiguro N. Impact of back muscle strength and aging on locomotive syndrome in community living Japanese women. Nagoya J Med Sci 2013;75:47–55.
   PubMed Web of Science ®Google Scholar
• Muramoto A, Imagama S, Ito Z, Hirano K, Tauchi R, Ishiguro N. Waist circumference is associated with locomotive syndrome in elderly females. J Orthop Sci. 2014;19:612–9.
   PubMed Web of Science ®Google Scholar
• Kazama JJ, Kutsuwada K, Ataka K, Maruyama H, Gejyo F. Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases. Nephron 2002;91:13–20.
   PubMed Web of Science ®Google Scholar
• Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 2002;48:699–707.
   PubMed Web of Science ®Google Scholar
• Meier P, Froidevaux C, Dayer E, Blanc E. Cystatin C concentration and glomerular filtration rate. Lancet. 2001;357:634–5.
   PubMed Web of Science ®Google Scholar
• Simonson O, Grubb A, Thysell H. The blood serum concentration of cystatin C (γ-trace) as a measure of the glomerular filtration rate. Scand J Clin Invest. 1985;45:97–101.
   PubMed Web of Science ®Google Scholar
• Abrahamson M, Olafsson I, Palsdottir A, Ulvsback M, Lundwall A, Jensson O, et al. Structure and expression of the human cystatin C gene. Biochem J. 1990;268:287–94.
   PubMed Web of Science ®Google Scholar
• Abrahamson M, Barrett AJ, Salvesen G, Grubb A. Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J Biol Chem. 1986;261:11282–9.
   PubMed Web of Science ®Google Scholar
• Henskens YM, Veerman ME, Amerongen AV. Cystatins in health and disease. Biol Chem Hoppe Seyler. 1996;377:71–86.
   PubMed Web of Science ®Google Scholar
• Pierre P, Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell. 1998;93:1135–45.
   PubMed Web of Science ®Google Scholar
• Kos J, Krašovec K, Cimerman N, Nielsen HJ, Christensen IJ, Brünner N. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. Clin Cancer Res. 2000;6:505–11.
   PubMed Web of Science ®Google Scholar
• Hammouda NE, Salah El-Din MA, El-Shishtawy MM, El-Gayar AM. Serum cystatin C as a biomarker in diffuse large B-cell lymphoma. Sci Pharm. 2017;85:9.
   Web of Science ®Google Scholar
• Çınar M, Aksoy RT, Güzel Aİ, Tokmak A, Çandar T, Taşçı Y. The predictive role of serum cystatin C levels in polycystic ovary syndrome in adolescents. J Pediatr Adolesc Gynecol. 2016;29:353–6.
   PubMed Web of Science ®Google Scholar
• Zhang M, Li Y, Yang X, Shan H, Zhang Q, Ming Z, et al. Serum cystatin C as an inflammatory marker in exacerbated and convalescent COPD patients. Inflammation. 2016;39:625–31.
   PubMed Web of Science ®Google Scholar
• Tanaka A, Suemaru K, Araki H. A new approach for evaluating renal function and its practical application. J Pharmacol Sci. 2007;105:1–5.
   PubMed Web of Science ®Google Scholar